Blepharospasm: Recent advances

Neurology

Volumn 59, Issue 9, 2002, Pages 1306-1312

  Hallett, Mark ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR;

BLEPHAROSPASM; DYSTONIA; ENVIRONMENTAL FACTOR; HEREDITY; HUMAN; NERVE CELL PLASTICITY; NEUROOPHTHALMOLOGY; NONHUMAN; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0037069257     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000027361.73814.0E     Document Type: Short Survey

References (71)

1. Aramideh M, Koelman JH, Speelman JD, Ongerboer de Visser B. Eyelid movement disorders and electromyography. Lancet 2001;357:805-806.
2. Tozlovanu V, Forget R, Iancu A, Boghen D. Prolonged orbicularis oculi activity: A major factor in apraxia of lid opening. Neurology 2001;57:1013-1018.
3. Aramideh M, Ongerboer de Visser BW, Koelman JHTM, Bour LJ, Devriese PP, Speelman JD. Clinical and electromyographic features of levator palpebrae superioris muscle dysfunction in involuntary eyelid closure. Mov Disord 1994;9:395-402.
4. Verghese J, Milling C, Rosenbaum DM. Ptosis, blepharospasm, and apraxia of eyelid opening secondary to putaminal hemorrhage. Neurology 1999;53:652.
5. Miranda M, Millar A. Blepharospasm associated with bilateral infarcts confined to the thalamus: Case report. Mov Disord 1998;13:616-617.
6. Singer C, Schatz NJ, Bowen B, et al. Asymmetric predominantly ipsilateral blepharospasm and contralateral parkinsonism in an elderly patient with a right mesencephalic cyst. Mov Disord 1998;13:135-139.
7. Castelbuono A, Miller NR. Spontaneous remission in patients with essential blepharospasm and Meige syndrome. Am J Ophthalmol 1998;126:432-435.
8. Tucha O, Naumann M, Berg D, Alders GL, Lange KW. Quality of life in patients with blepharospasm. Acta Neurol Scand 2001;103:49-52.
9. Wenzel T, Schnider P, Griengl H, Birner P, Nepp J, Auff E. Psychiatric disorders in patients with blepharospasm - A reactive pattern? J Psychosom Res 2000;48:589-591.
10. Nakashima K, Kusumi M, Inoue Y, Takahashi K. Prevalence of focal dystonias in the western area of Tottori Prefecture in Japan. Mov Disord 1995;10:440-443.
11. Nutt JG, Muenter MD, Aronson A, Kurland LT, Melton LJD. Epidemiology of focal and generalized dystonia in Rochester, Minnesota. Mov Disord 1988;3:188-194.
12. Duffey PO, Butler AG, Hawthorne MR, Barnes MP. The epidemiology of the primary dystonias in the North of England. In: Fahn S, Marsden CD, DeLong MR, eds. Dystonia 3. (Advances in Neurology, vol 78.) Philadelphia: Lippincott-Raven, 1998:121-126.
13. A prevalence study of primary dystonia in eight European countries. J Neurol 2000;247:787-792.
14. Defazio G, Livrea P, De Salvia R, et al. Prevalence of primary blepharospasm in a community of Puglia region, Southern Italy. Neurology 2001;56:1579-1581.
15. Epidemiologic Study of Dystonia in Europe (ESDE) Collaborative Group. Sex-related influences on the frequency and age of onset of primary dystonia. Neurology 1999;53:1871-1873.
16. Defazio G, Berardelli A, Abbruzzese G, et al. Possible risk factors for primary adult onset dystonia: A case-control investigation by the Italian Movement Disorders Study Group. J Neurol Neurosurg Psychiatry 1998;64:25-32.
17. Stojanovic M, Cvetkovic D, Kostic VS. A genetic study of idiopathic focal dystonias. J Neurol 1995;242:508-511.
18. Schrag A, Bhatia KP, Quinn NP, Marsden CD. Atypical and typical cranial dystonia following dental procedures. Mov Disord 1999;14:492-496.
19. Soonawala N, Bhatia KP, Yeung JH, Quinn NP, Marsden CD. Idiopathic blepharospasm does not lead to a parkinsonian syndrome: Results of a questionnaire-based follow-up study. J Neurol 1999;246:283-286.
20. Defazio G, Berardelli A, Abbruzzese G, et al. Risk factors for spread of primary adult onset blepharospasm: A multicentre investigation of the Italian movement disorders study group. J Neurol Neurosurg Psychiatry 1999;67:613-619.
21. Schaumberg DA, Buring JE, Sullivan DA, Dana MR. Hormone replacement therapy and dry eye syndrome. JAMA 2001;286:2114-2119.
22. Hallett M, Daroff RB. Blepharospasm: Report of a workshop. Neurology 1996;46:1213-1218.
23. May PJ, Porter JD. The distribution of primary afferent terminals from the eyelids of macaque monkeys. Exp Brain Res 1998;123:368-381.
24. May PJ, Baker RG, Chen B. The eyelid levator muscle: Servant of two masters. Mov Disord 2002;17(suppl 2):S4-S7.
25. Jenny AB, Saper CB. Organization of the facial nucleus and corticofacial projection in the monkey. Neurology 1987;37:930-939.
26. Morecraft RJ, Louie JL, Herrick JL, Stilwell-Morecraft KS. Cortical innervation of the facial nucleus in the non-human primate: A new interpretation of the effects of stroke and related subtotal brain trauma on the muscles of facial expression. Brain 2001;124:176-208.
27. Berardelli A, Rothwell JC, Hallett M, Thompson PD, Manfredi M, Marsden CD. The pathophysiology of primary dystonia. Brain 1998;121:1195-1212.
28. Hallett M. The neurophysiology of dystonia. Arch Neurol 1998;55:601-603.
29. Hallett M. Plasticity and basal ganglia disorders. In: Kultas-Ilinsky K, Ilinsky IA, eds. Basal Ganglia and Thalamus in Health and Movement Disorders. New York: Kluwer Academic/Plenum Publishers, 2001;197-204.
30. Byl N, Merzenich MM, Jenkins WM. A primate genesis model of focal dystonia and repetitive strain injury: I. Learning-induced dedifferentiation of the representation of the hand in the primary somatosensory cortex in adult monkeys. Neurology 1996;47:508-520.
31. Byl NN, Merzenich MM, Cheung S, Bedenbaugh P, Nagarajan SS, Jenkins WM. A primate model for studying focal dystonia and repetitive strain injury: Effects on the primary somatosensory cortex. Phys Ther 1997;77:269-284.
32. Schicatano EJ, Basso MA, Evinger C. Animal model explains the origins of the cranial dystonia benign essential blepharospasm. J Neurophysiol 1997;77:2842-2846.
33. Basso MA, Powers AS, Evinger C. An explanation for reflex blink hyperexcitability in Parkinson's disease. I. Superior colliculus. J Neurosci 1996;16:7308-7317.
34. Baker RS, Sun WS, Hasan SA, et al. Maladaptive neural compensatory mechanisms in Bell's palsy-induced blepharospasm. Neurology 1997;49:223-229.
35. Chuke JC, Baker RS, Porter JD. Bell's palsy-associated blepharospasm relieved by aiding eyelid closure. Ann Neurol 1996;39:263-268.
36. Manca D, Munoz E, Pastor P, Valldeoriola F, Valls-Sole J. Enhanced gain of blink reflex responses to ipsilateral supraorbital nerve afferent inputs in patients with facial nerve palsy. Clin Neurophysiol 2001;112:153-156.
37. Syed NA, Delgado A, Sandbrink F, Schulman AE, Hallett M, Floeter MK. Blink reflex recovery in facial weakness: An electrophysiologic study of adaptive changes. Neurology 1999;52:834-838.
38. Gomez-Wong E, Marti MJ, Cossu G, Fabregat N, Tolosa ES, Valls-Sole J. The 'geste antagonistique' induces transient modulation of the blink reflex in human patients with blepharospasm. Neurosci Lett 1998;251:125-128.
39. Gomez-Wong E, Marti MJ, Tolosa E, Valls-Sole J. Sensory modulation of the blink reflex in patients with blepharospasm. Arch Neurol 1998;55:1233-1237.
40. Eidelberg D, Moeller JR, Antonini A, et al. Functional brain networks in DYT1 dystonia. Ann Neurol 1998;44:303-312.
41. Hutchinson M, Nakamura T, Moeller JR, et al. The metabolic topography of essential blepharospasm: A focal dystonia with general implications. Neurology 2000;55:673-677.
42. Esmaeli-Gutstein B, Nahmias C, Thompson M, Kazdan M, Harvey J. Positron emission tomography in patients with benign essential blepharospasm. Ophthal Plast Reconstr Surg 1999;15:23-27.
43. Black KJ, Ongur D, Perlmutter JS. Putamen volume in idiopathic focal dystonia. Neurology 1998;51:819-824.
44. Federico F, Simone IL, Lucivero V, et al. Proton magnetic resonance spectroscopy in primary blepharospasm. Neurology 1998;51:892-895.
45. Perlmutter JS, Tempel LW, Black KJ, Parkinson D, Todd RD. MPTP induces dystonia and parkinsonism. Clues to the pathophysiology of dystonia. Neurology 1997;49:1432-1438.
46. Todd RD, Perlmutter JS. Mutational and biochemical analysis of dopamine in dystonia: Evidence for decreased dopamine D2 receptor inhibition. Mol Neurobiol 1998;16:135-147.
47. 18F]spiperone binding in putamen in idiopathic focal dystonia. J Neurosci 1997;17:843-850.
48. 123I] beta-CIT. Mov Disord 1998;13:319-323.
49. Mink JW. The basal ganglia: Focused selection and inhibition of competing motor programs. Prog Neurobiol 1996;50:381-425.
50. Hershey T, Black KJ, Carl JL, Perlmutter JS. Dopa-induced blood flow responses in nonhuman primates. Exp Neurol 2000;166:342-349.
51. Black KJ, Hershey T, Gado MH, Perlmutter JS. Dopamine D(1) agonist activates temporal lobe structures in primates. J Neurophysiol 2000;84:549-557.
52. Black KJ, Gado MH, Perlmutter JS. PET measurement of dopamine D2 receptor-mediated changes in striatopallidal function. J Neurosci 1997;17:3168-3177.
53. Hershey T, Black KJ, Stambuk MK, Carl JL, McGee-Minnich LA, Perlmutter JS. Altered thalamic response to levodopa in Parkinson's patients with dopa-induced dyskinesias. Proc Natl Acad Sci USA 1998;95:12016-12021.
54. Tempel LW, Perlmutter JS. Abnormal cortical responses in patients with writer's cramp. Neurology 1993;43:2252-2257.
55. Feiwell RJ, Black KJ, McGee-Minnich LA, Snyder AZ, Mac-Leod AM, Perlmutter JS. Diminished regional cerebral blood flow response to vibration in patients with blepharospasm. Neurology 1999;52:291-297.
56. Ceballos-Baumann AO, Passingham RE, Warner T, Playford ED, Marsden CD, Brooks DJ. Overactive prefrontal and underactive motor cortical areas in idiopathic dystonia. Ann Neurol 1995;37:363-372.
57. Ibanez V, Sadato N, Karp B, Deiber MP, Hallett M. Deficient activation of the motor cortical network in patients with writer's cramp. Neurology 1999;53:96-105.
58. Jost WH, Kohl A. Botulinum toxin: Evidence-based medicine criteria in blepharospasm and hemifacial spasm. J Neurol 2001;248(suppl 1):21-24.
59. Kowal L. Pretarsal injections of botulinum toxin improve blephospasm in previously unresponsive patients. J Neurol Neurosurg Psychiatry 1997;63:556.
60. Mackie IA. Riolan's muscle: Action and indications for botulinum toxin injection. Eye 2000;14:347-352.
61. Wirtschafter JD, McLoon LK. Long-term efficacy of local doxorubicin chemomyectomy in patients with blepharospasm and hemifacial spasm. Ophthalmology 1998;105:342-346.
62. Anderson RL, Patel BC, Holds JB, Jordan DR. Blepharospasm: Past, present, and future. Ophthal Plast Reconstr Surg 1998;14:305-317.
63. Good PA, Taylor RH, Mortimer MJ. The use of tinted glasses in childhood migraine. Headache 1991;31:533-536.
64. Ridding MC, Sheean G, Rothwell JC, Inzelberg R, Kujirai T. Changes in the balance between motor cortical excitation and inhibition in focal, task specific dystonia. J Neurol Neurosurg Psychiatr 1995;59:493-498.
65. Chen R, Classen J, Gerloff C, et al. Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation. Neurology 1997;48:1398-1403.
66. Siebner HR, Tormos JM, Ceballos-Baumann AO, et al. Low-frequency repetitive transcranial magnetic stimulation of the motor cortex in writer's cramp. Neurology 1999;52:529-537.
67. McCann JD, Gauthier M, Morschbacher R, et al. A novel mechanism for benign essential blepharospasm. Ophthal Plast Reconstr Surg 1999;15:384-389.
68. Stanton-Hicks M. Complex regional pain syndrome (type I, RSD; type II, causalgia): Controversies. Clin J Pain 2000;16:S33-S40.
69. Marchettini P, Lacerenza M, Formaglio F. Sympathetically maintained pain. Curr Rev Pain 2000;4:99-104.
70. Manning DC. Reflex sympathetic dystrophy, sympathetically maintained pain, and complex regional pain syndrome: Diagnoses of inclusion, exclusion, or confusion? J Hand Ther 2000;13:260-268.
71. Ochoa JL. Truths, errors, and lies around "reflex sympathetic dystrophy" and "complex regional pain syndrome." J Neurol 1999;246:875-879.